Brought to you by The National Council for Mental Wellbeing

We are in the midst of a mental health epidemic that has been exacerbated by the COVID-19 pandemic. For patients living with major depressive disorder, this puts further strain on a population that has seen little treatment innovation in decades, leaving millions inadequately served by current options. The recent reemergence of research and development of psychedelic therapies is demonstrating potential for new treatments, but also creates new challenges of reimagining care delivery, measuring outcomes, and training the workforce to develop new skills. During this webinar we will explore the research, science, and considerations in the area of psychedelic therapies for mental health.

Register